Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences

COVID-19 anosmia pathogenesis based on 18F-FDG PET studies

Mahsa Eskian, Thomas Werner, Babak Saboury, Abass Alavi and Mona-Elisabeth Revheim
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2645;
Mahsa Eskian
1MGH/Harvard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Werner
2Hospital of the University of Pennsylvania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Babak Saboury
3National Institutes of Health (NIH) - Clinical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abass Alavi
4University of Pennsylvania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mona-Elisabeth Revheim
5Oslo University Hospital and University of Oslo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

2645

Introduction: Hyposmia (diminished sense of smell) and anosmia (total loss of the sense of smell) have been reported as relatively common complications in patients with coronavirus disease-2019 (COVID-19) infection. Unlike the loss of smell or taste in common viral rhinitis, the hyposmia/anosmia of COVID-19 is reported to happen in the absence of nasal congestion or paranasal sinuses abnormality. Moreover, anosmia in COVID-19 may last for weeks to months following the COVID-19 acute phase. In this study, we tried to investigate the potential pathogenesis of hyposmia or anosmia in COVID-19 infection based on 18F-FDG PET brain studies.

Methods: A comprehensive literature review was performed in the MEDLINE, Embase, Cochrane library databases, and Web of Science. The search results were screened for English studies including case reports/series, cohort studies, and clinical trials regarding brain imaging in patients with COVID-19 infection and anosmia, hyposmia, or parosmia without any publication date limitation. Included papers were reviewed regarding the study design, patient population, and outcomes.

Results: Magnetic resonance imaging (MRI) of patients with COVID-19 induced anosmia were mostly reported normal in both morphology and signal intensity of the olfactory bulb. Moreover, paranasal sinuses were reported normal in CT scan studies. However, 18F-FDG PET studies showed a reduction of glucose uptake in the dominant orbitofrontal cortex, insula, inferior frontal gyrus, and cerebellar vermis. Same pathological patterns were also reported in the 18F-FDG PET studies of cases with parosmia (dysfunctional smell detection) following COVID-19 infection.

The pathological patterns reported in brain 18F-FDG-PET studies can be explained by the impaired neural function due to direct neurotropism of severe acute respiratory syndrome coronavirus 2 (sars-CoV-2) due to expression of angiotensin-converting enzyme 2 (ACE2) on the nervous system cells, especially in the olfactory cortex.

Conclusions: Anosmia has been reported as one of the complications following the acute course of COVID-19 infection. 18F-FDG PET studies of patients with COVID-19 induced hyposmia, anosmia or parosmia showed decreased metabolic activity of the orbitofrontal cortex which can be a result of direct viral neurotropism. More 18F-FDG PET studies can help us in a better understanding of the reletivley long lasting neurologic complications of COVID-19.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 anosmia pathogenesis based on 18F-FDG PET studies
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
COVID-19 anosmia pathogenesis based on 18F-FDG PET studies
Mahsa Eskian, Thomas Werner, Babak Saboury, Abass Alavi, Mona-Elisabeth Revheim
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2645;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
COVID-19 anosmia pathogenesis based on 18F-FDG PET studies
Mahsa Eskian, Thomas Werner, Babak Saboury, Abass Alavi, Mona-Elisabeth Revheim
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2645;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • PET CT Quantification to direct Alzheimer’s patients to anti-amyloid therapy
  • Multicenter trial study for usefulness of physical parameters toward the standardization of brain SPECT image: relation to visual analysis
  • Assessment of Brain Perfusion 123I-IMP SPECT imaging Using Low Energy High Resolution Collimator image reconstructed by Flash 3D
Show more Neurosciences

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire